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Lifelong ART for 
20 million people in 
sub-Saharan Africa: 
communities will be 
key for success
At the end of 2012, 9·7 million 
people accessed antiretroviral therapy 
(ART) in resource-limited settings.1 
Scale-up of ART in the past decade 
is estimated to have averted more 
than 4 million deaths. Nevertheless, 
an additional 16 million people are 
eligible for treatment under the new 
WHO guidelines1 but are yet to receive 
it, most of whom are in sub-Saharan 
Africa; all HIV positive individuals will 
eventually need ART.2 Inevitably these 
guidelines will aﬀ ect societies in high-
prevalence settings, where up to a 
third of the adult population will have 
to change their lifestyle to adhere to 
lifelong care and treatment.
Increasing evidence shows the 
potential for community participation 
to reinforce the continuum along 
the care pathway. First, uptake of 
HIV testing can increase rapidly 
through application of home-
based and community-based HIV 
testing strategies.3 Moreover, new 
technologies such as self-testing with 
rapid oral tests oﬀ er great potential 
for self-management and community 
participation.4 Second, new simple 
technologies such as point-of-care 
CD4 cell tests favour community 
participation, and result in a reduction 
of the time to eligibility assessment.5 
Another strategy that has been 
proposed, but not yet fully evaluated, is 
for community health workers (CHWs) 
or trained expert patients to initiate 
ART for clinically stable and eligible 
patients within their community.6 Such 
a demedicalised approach would not 
have been possible to contemplate 
only a few years ago when most 
patients presented late, with multiple 
comorbidities, and when ART needed 
careful supervision. Although late 
presentation is a challenge, overall, 
people are seeking care when less sick, 
treatment guidelines are encouraging 
earlier initiation of ART, and the 
standard ﬁ rst-line ART is far less toxic 
and easier to administer than past 
drugs.2 Furthermore, simple screening 
instruments to rule out tuberculosis 
with simple questionnaires have 
been validated.7 Finally, several 
studies have shown that delivery 
of ART within the community is 
associated with sustained retention 
and adherence.8 CHWs can assure 
ART supply within their communities, 
including through home-based de-
liv ery.9 Other approaches to com-
munity ART in clude monthly reﬁ lls at 
community pharmacies or rotation of 
community support group members 
who pick up ART for the whole group 
at health facilities. In Mozambique, 
this rotation approach resulted in 
more than 90% retention at 4 years, 
which shows that retention is greatly 
enhanced when people living with HIV/
AIDS have an active role in the daily 
management of their disorder.9,10 These 
community-based interventions have 
been piloted in isolation, in diﬀ erent 
settings, but can be brought together 
into an overarching comprehensive 
HIV care model that recognises the 
contribution of these community-
based interventions as a central part of 
the overall response.
For this to work, ﬁ rst, community-
driven programmes need to be 
designed in collaboration with the 
expected beneﬁ ciaries because the 
sustainability of the community pro-
gram me depends on the development 
of leadership and bonding trust 
relation ships. Second, a community-
driven chronic care model can work 
only if a functional referral system 
is in place for people who fall ill. 
Finally, community models come 
at a cost, in particular the need to 
ensure remuneration for lay workers; 
however, these costs are small 
compared with the costs associated 
with clinic-based care.9
Nevertheless, we believe that a 
comprehensive community-driven HIV 
care model which assures a continuum 
for uptake, linkage, and retention 
could be the way to go to address the 
enormous challenges of weak health 
systems and uncovered patient’s needs 
in the most aﬀ ected countries.
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